ATE356831T1 - Neuer galaninrezeptor - Google Patents
Neuer galaninrezeptorInfo
- Publication number
- ATE356831T1 ATE356831T1 AT97933938T AT97933938T ATE356831T1 AT E356831 T1 ATE356831 T1 AT E356831T1 AT 97933938 T AT97933938 T AT 97933938T AT 97933938 T AT97933938 T AT 97933938T AT E356831 T1 ATE356831 T1 AT E356831T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- galanin receptor
- new
- directed
- nucleic acids
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 102000019432 Galanin Human genes 0.000 abstract 1
- 101800002068 Galanin Proteins 0.000 abstract 1
- 102000001968 Galanin receptor 2 Human genes 0.000 abstract 1
- 108050009373 Galanin receptor 2 Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9602822A SE9602822D0 (sv) | 1996-07-19 | 1996-07-19 | New receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356831T1 true ATE356831T1 (de) | 2007-04-15 |
Family
ID=20403435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97933938T ATE356831T1 (de) | 1996-07-19 | 1997-07-04 | Neuer galaninrezeptor |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6562945B1 (de) |
| EP (1) | EP0912610B1 (de) |
| AT (1) | ATE356831T1 (de) |
| AU (1) | AU3711597A (de) |
| CA (1) | CA2260745A1 (de) |
| DE (1) | DE69737476T2 (de) |
| ES (1) | ES2283024T3 (de) |
| SE (1) | SE9602822D0 (de) |
| WO (1) | WO1998003548A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997026853A2 (en) | 1996-01-24 | 1997-07-31 | Synaptic Pharmaceutical Corporation | Dna encoding galanin galr2 receptors and uses thereof |
| US6410686B1 (en) | 1996-06-05 | 2002-06-25 | Bayer Corporation | Galanin receptor 2 protein |
| US6329197B2 (en) | 1996-10-09 | 2001-12-11 | Synaptic Pharmaceutical Corporation | DNA encoding galanin GALR3 receptors and uses thereof |
| EP0948532A4 (de) * | 1996-12-27 | 2002-09-25 | Merck & Co Inc | Galanin rezeptor galr2 der maus und dafür kodierende nukleotide |
| EP1037913A4 (de) | 1997-12-17 | 2002-11-20 | Merck & Co Inc | Galanin rezeptor galr3 und für diesen kodierende nukleotide |
| US6337206B1 (en) | 1997-12-18 | 2002-01-08 | Merck & Co., Inc. | Nucleic acid encoding mouse galanin receptor (GALR2) |
| JP2002536989A (ja) * | 1999-02-24 | 2002-11-05 | メルク エンド カムパニー インコーポレーテッド | ガラニン受容体と類似したｇタンパク質共役受容体 |
| WO2000055318A2 (en) | 1999-03-15 | 2000-09-21 | University Of British Columbia | Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| CA2381979A1 (en) * | 1999-08-17 | 2001-02-22 | Klaus Ducker | Pgpcr-3 polypeptides and dna sequences thereof |
| US20050240008A1 (en) * | 2000-03-30 | 2005-10-27 | Tetsuya Ohtaki | Novel protein, dna thereof and process for producing the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1462692A (en) * | 1991-02-25 | 1992-09-15 | Board Of Regents Of The University Of Washington, The | Methods for detecting galanin antagonists |
| FR2716205B1 (fr) * | 1994-02-17 | 1996-04-12 | Rhone Poulenc Rorer Sa | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. |
| US5712111A (en) * | 1994-04-15 | 1998-01-27 | Merck & Co., Inc. | DNA encoding bradykinin B1 receptor |
| EP0711830A3 (de) | 1994-10-13 | 1997-06-11 | Takeda Chemical Industries Ltd | Menschlicher und muriner Galanin Rezeptor |
| WO1997026853A2 (en) | 1996-01-24 | 1997-07-31 | Synaptic Pharmaceutical Corporation | Dna encoding galanin galr2 receptors and uses thereof |
| US5972624A (en) | 1996-01-24 | 1999-10-26 | Synaptic Pharmaceutical Corporation | Method of identifying ligands which bind recombinant galanin receptor (GALR2) |
| US6410686B1 (en) * | 1996-06-05 | 2002-06-25 | Bayer Corporation | Galanin receptor 2 protein |
| CA2256523A1 (en) | 1996-06-05 | 1997-12-11 | Bayer Corporation | Galanin receptor galr2 |
| EP0948532A4 (de) | 1996-12-27 | 2002-09-25 | Merck & Co Inc | Galanin rezeptor galr2 der maus und dafür kodierende nukleotide |
-
1996
- 1996-07-19 SE SE9602822A patent/SE9602822D0/xx unknown
-
1997
- 1997-07-04 EP EP97933938A patent/EP0912610B1/de not_active Expired - Lifetime
- 1997-07-04 US US08/981,700 patent/US6562945B1/en not_active Expired - Fee Related
- 1997-07-04 ES ES97933938T patent/ES2283024T3/es not_active Expired - Lifetime
- 1997-07-04 AU AU37115/97A patent/AU3711597A/en not_active Abandoned
- 1997-07-04 AT AT97933938T patent/ATE356831T1/de not_active IP Right Cessation
- 1997-07-04 DE DE69737476T patent/DE69737476T2/de not_active Expired - Lifetime
- 1997-07-04 CA CA002260745A patent/CA2260745A1/en not_active Abandoned
- 1997-07-04 WO PCT/SE1997/001217 patent/WO1998003548A1/en not_active Ceased
-
2003
- 2003-02-06 US US10/359,285 patent/US7528229B2/en not_active Expired - Fee Related
-
2006
- 2006-04-18 US US11/407,027 patent/US7375207B2/en not_active Expired - Fee Related
- 2006-04-18 US US11/407,004 patent/US7407761B2/en not_active Expired - Fee Related
- 2006-04-18 US US11/407,026 patent/US7510846B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU3711597A (en) | 1998-02-10 |
| EP0912610A1 (de) | 1999-05-06 |
| SE9602822D0 (sv) | 1996-07-19 |
| DE69737476D1 (de) | 2007-04-26 |
| US7510846B2 (en) | 2009-03-31 |
| EP0912610B1 (de) | 2007-03-14 |
| US7407761B2 (en) | 2008-08-05 |
| US20060234282A1 (en) | 2006-10-19 |
| US20060234281A1 (en) | 2006-10-19 |
| US7528229B2 (en) | 2009-05-05 |
| DE69737476T2 (de) | 2007-12-06 |
| US6562945B1 (en) | 2003-05-13 |
| ES2283024T3 (es) | 2007-10-16 |
| CA2260745A1 (en) | 1998-01-29 |
| WO1998003548A1 (en) | 1998-01-29 |
| US20030187222A1 (en) | 2003-10-02 |
| US20060235202A1 (en) | 2006-10-19 |
| US7375207B2 (en) | 2008-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971875D0 (no) | Cathepsin 02 protease | |
| DE69528061D1 (de) | Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren | |
| PL341524A1 (en) | Novel receptor coupled wih g protein | |
| DE69518751D1 (de) | Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend | |
| DK1095140T3 (da) | Neurotrofe faktorer | |
| BG103091A (en) | Shortened soluble receptors of type i & ii of the tumour necrotizing factor | |
| NL300272I1 (nl) | DNA dat humaan papillomavirus type 18 codeert. | |
| TR199802394A3 (tr) | Proteinleri stabilize etmek için gelistirilmis proses. | |
| DE69938240D1 (de) | Neuer g-protein-gekoppelter rezeptor | |
| DE69737651D1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
| ATE356831T1 (de) | Neuer galaninrezeptor | |
| BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
| ATE285474T1 (de) | Haemophilus adhäsionsproteinen | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
| SE9604439D0 (sv) | New receptor | |
| PE20399A1 (es) | Muteina ob | |
| ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| LV12722A (lv) | Prv-1 gene and the use thereof | |
| SE9804274D0 (sv) | Novel receptor | |
| EA200100110A1 (ru) | Нейротрофические факторы | |
| MX9701904A (es) | Proteinas de enlace de pka novedosas y usos de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |